UPDATE: Leerink Swann Upgrades Array BioPharma (ARRY) to Outperform; Exciting Data Help Leverage to MEK Inhibitors
Tweet Send to a Friend
(Updated - August 15, 2012 10:31 AM EDT)
Leerink Swann upgraded Array BioPharma (NASDAQ: ARRY) from Market Perform to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Leerink Swann upgraded Array BioPharma (NASDAQ: ARRY) from Market Perform to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
